Does thymosin alpha-1 boost immunity?
One large trial in people with sepsis found no clear evidence that it reduced deaths over 28 days. That doesn’t settle every possible use. It does show why a big trial and a positive result are different things.
13 of 16 in Every Peptide Explained in 10 Minutes (Human Studies Only)
What the human studies found
- A peptide from the thymus, often promoted for immune support. FDA warning letters document sellers promoting it for immune health.
- The trial (TESTS, BMJ 2025) was multicentre, double-blind and placebo-controlled, in adults with sepsis, a life-threatening response to infection.
- It found no clear evidence that thymosin alpha-1 reduced deaths from any cause over 28 days.
The studies (2)
Also cited
We checked the human research behind 16 peptides. The question wasn’t just “is there a study?” It was “does that study support the pitch?” For each one: who took part, what was measured, and what actually changed.
Watch all 16, explained: the film on YouTube · 9:42An approval, a trial or a paper belongs to a particular substance and a particular use. None of it verifies the contents of a bottle sold online. This is an investigation of the claims, not a guide to taking them.
Get the free 3-question checklist
The three questions we asked of all 16 peptides, plus each new investigation when it drops. No spam, unsubscribe anytime.